NICHOLAS PARKER: Open Payments
NPI 1164159893 · CROSSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 22 payments from 8 companies in 2025. Trend: 2023 $575 · 2024 $432 · 2025 $679
Food & beverage: $581Education: $98
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $268 |
| Galderma Laboratories, L.P. | 2 | $142 |
| GENZYME CORPORATION | 3 | $93 |
| UCB, Inc. | 1 | $71 |
| ABBVIE INC. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| LEO Pharma Inc. | 1 | $26 |
| Organogenesis Inc. | 1 | $15 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, Rhapsido, ADBRY, RINVOQ, SKYRIZI, CYGNUS DUAL.
Industry payments across TN — which companies pay providers there.
